A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
Lyne Gagnon(ProMetic Life Sciences (United States)), Pierre Laurin
Cited by 134
Related Papers
PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
|Journal of Pharmacology and Experimental Therapeutics|2018|28